|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
|
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash, cash equivalents and restricted cash | ||||||||
| Cash and cash equivalents | ||||||||
| Restricted cash | ||||||||
| Total cash, cash equivalents and restricted cash | ||||||||
| Accounts receivable, net | ||||||||
| Due from related parties | ||||||||
| Inventories, net | ||||||||
| Prepaid expenses and other current assets | ||||||||
| Total Current Assets | ||||||||
| Investments | ||||||||
| Property, plant and equipment, net | ||||||||
| Intangible assets, net | ||||||||
| Goodwill | ||||||||
| Other assets | ||||||||
| Total Assets | ||||||||
| Liabilities and Stockholders' Equity | ||||||||
| Accounts payable | ||||||||
| Related party | ||||||||
| Nonrelated party | ||||||||
| Total accounts payable | ||||||||
| Accrued employee benefits | ||||||||
| Accrued expenses | ||||||||
| Contract liabilities | ||||||||
| Notes payable - current | ||||||||
| Related party | ||||||||
| Nonrelated party | ||||||||
| Embedded derivative liability | ||||||||
| Notes payable - current | ||||||||
| Term convertible note, current | ||||||||
| Related party | ||||||||
| Nonrelated party | ||||||||
| Total term convertible note, current | ||||||||
| Convertible promissory note, current | ||||||||
| Patent installment payable - current | ||||||||
| Liability for future preferred stock issuance | ||||||||
| Obligation to issue equity | ||||||||
| Series B Preferred Stock | ||||||||
| Series C Preferred Stock | ||||||||
| Total obligation to issue equity | ||||||||
| Warrant liability | ||||||||
| Income taxes payable | ||||||||
| Other current liabilities | ||||||||
| Total Current Liabilities | ||||||||
| Notes payable, net of current portion | ||||||||
| Convertible notes, net of current portion | ||||||||
| Related party | ||||||||
| Nonrelated party | ||||||||
| Earnout liability | ||||||||
| Stock-based compensation liability | ||||||||
| Patent installment payable, net of current portion | ||||||||
| Deferred income taxes | ||||||||
| Other liabilities | ||||||||
| Total Liabilities | ||||||||
| Redeemable Units | ||||||||
| Redeemable Class I Units | ||||||||
| Redeemable Class PCTA Units | ||||||||
| Total redeemable Units | ||||||||
| Preferred Stock, $0.0001 par value, 25,000,000 shares authorized, 2,885,848 and — shares issued and outstanding as of March 31, 2025 and December 31, 2024, respectively | ||||||||
| Stockholders' Equity | ||||||||
| Preferred stock | ||||||||
| Class B Preferred | ||||||||
| Class B-1 Preferred Units | ||||||||
| Series B Preferred Stock | ||||||||
| Series C Preferred Stock | ||||||||
| Total preferred stock | ||||||||
| Common stock | ||||||||
| Class A | ||||||||
| Class C Units | ||||||||
| Total common stock | ||||||||
| Additional paid-in capital | ||||||||
| Accumulated other comprehensive loss | ||||||||
| Accumulated deficit | ||||||||
| Total Innventure, Inc., Stockholders’ Equity | ||||||||
| Non-controlling interest | ||||||||
| Total Stockholders' Equity | ||||||||
| Total Liabilities and Stockholders' Equity |
Loading...
